Ana Espinosa Selected Research

Ana Espinosa Research Topics

Disease

30	Neoplasms (Cancer) 10/2023 - 11/2004
20	Cognitive Dysfunction 02/2024 - 01/2013
18	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2013
10	Dementia (Dementias) 02/2024 - 09/2009
8	Hyperthermia 10/2023 - 04/2012
6	Breast Neoplasms (Breast Cancer) 09/2023 - 09/2015
5	Infections 01/2023 - 11/2021
3	Genetic Risk Score 02/2024 - 01/2016
3	Birth Weight (Birth Weights) 01/2018 - 04/2015
2	Ganglion Cysts (Ganglion) 02/2024 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 09/2023 - 01/2021
2	Inflammation (Inflammations) 01/2023 - 12/2021
2	Disease Progression 01/2022 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2017
2	Lymphoma (Lymphomas) 08/2013 - 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 12/2023
1	Glioblastoma (Glioblastoma Multiforme) 07/2023
1	Amyloidosis 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Hyperhidrosis 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Pain (Aches) 01/2023
1	Diabetes Mellitus 01/2023
1	Neuroblastoma 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Breakthrough Infections 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Asymptomatic Infections 11/2021
1	Primrose syndrome 01/2021

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2013
11	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2013
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2015
6	ferric oxide (iron oxide)IBA 07/2023 - 04/2012
5	Retinaldehyde (Retinal)IBA 02/2024 - 11/2018
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
4	mahuang-tangIBA 10/2023 - 03/2015
4	Hormones (Hormone)IBA 01/2022 - 05/2015
3	GoldIBA 07/2023 - 12/2015
3	Amyloid beta-PeptidesIBA 01/2023 - 01/2013
3	Immunoglobulin G (IgG)IBA 01/2022 - 11/2021
3	Immunoglobulin A (IgA)IBA 01/2022 - 11/2021
3	AntibodiesIBA 01/2022 - 11/2021
3	TrihalomethanesIBA 12/2021 - 11/2016
3	SuspensionsIBA 11/2021 - 12/2015
3	ApolipoproteinsIBA 05/2018 - 01/2016
2	VaccinesIBA 01/2023 - 01/2022
2	MelatoninIBA 01/2022 - 07/2014
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 05/2015
2	Chloroform (Trichloromethane)IBA 12/2021 - 01/2017
2	Drinking WaterIBA 12/2021 - 01/2017
2	cupric sulfide (CuS)IBA 01/2021 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 03/2015
2	CarcinogensIBA 01/2016 - 09/2015
1	ZincIBA 12/2023
1	IronIBA 10/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023
1	Contrast MediaIBA 10/2023
1	IonsIBA 10/2023
1	Aspartame (NutraSweet)IBA 09/2023
1	Sweetening Agents (Sweeteners)IBA 09/2023
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2023
1	Neuroprotective AgentsIBA 01/2023
1	AntioxidantsIBA 01/2023
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2023
1	Benzydamine (Tantum)IBA 01/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023
1	AntiperspirantsIBA 01/2023
1	Ginkgo biloba extract (Rokan)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	Matrix Metalloproteinase 10 (Stromelysin 2)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	Epidermal Growth Factor (EGF)IBA 12/2021
1	PeriostinIBA 12/2021
1	NitratesIBA 12/2021
1	Immunoglobulin M (IgM)IBA 11/2021
1	AntigensIBA 11/2021
1	sharpinIBA 01/2021
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2021
1	EnzymesIBA 01/2020
1	CopperIBA 01/2019
1	Sulfides (Thioethers)IBA 01/2019
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	PolymersIBA 08/2017
1	NanogelsIBA 08/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017
1	Ether (Diethyl Ether)IBA 08/2017
1	MethacrylatesIBA 08/2017
1	methacrylic acidIBA 08/2017
1	Ethylene Glycol (Monoethylene Glycol)IBA 08/2017

Therapy/Procedure

9	Therapeutics 10/2023 - 03/2015
5	Photothermal Therapy 01/2020 - 12/2015
3	Photochemotherapy (Photodynamic Therapy) 01/2019 - 03/2015
3	Lasers (Laser) 02/2016 - 03/2015
2	Induced Hyperthermia (Thermotherapy) 10/2023 - 01/2016
1	Injections 01/2023
1	Aftercare (After-Treatment) 01/2023